Brand Name Statins Still Favored by Consumers: Treato Ranks Top Statins Based on Consumer Experiences of Overall Satisfaction, Helpfulness and Concerns
Merck's Vytorin Tops List Based on Overall Consumer Satisfaction
NEW YORK, Jan. 27, 2016 /PRNewswire/ -- Today Treato, a leading consumer healthcare website, revealed their first annual list of top statins. This ranking is part of a new series of drug rankings from the company. Statins are one of the most commonly used medications to treat high cholesterol and reduce the risk of heart disease. Statins work by blocking cholesterol's production in the liver. The U.S. Preventative Services Task Force recently announced their recommendation that adults as young as 40 without a previous heart attack should consider starting a low dose statin. Merck formulations took the top two spots with Vytorin, at the top of the brand list and lovastatin, the generic for Merck's Mevacor, at the top of the generics list. Despite generics for statins being on the market for many years, consumers are still favoring brand name statins as many brand names scored higher in overall satisfaction than generics. Among popular statins, Bristol Myers Squibb's Pravachol is the statin with the highest rate of posts discussing concerns, while lovastatin has the lowest rate.
Treato's Top List Of Statins:
(5 being the highest and 1 the lowest score)
Brand:
Drug |
Manufacture |
Price* |
Satisfaction (Overall) |
Helpfulness Score |
Concern Score |
1. Vytorin** |
Merck |
$233.53 (20mg) |
2.4 |
5 |
3.9 |
2. Zocor |
Merck |
$216.57 (20mg) |
2.1 |
3.3 |
4 |
3. Crestor |
AstraZeneca |
$236.14 (10mg) |
1.8 |
2.7 |
3.6 |
4. Pravachol |
Bristol-Myers Squibb |
$170.51 (40mg) |
1.7 |
1.7 |
4.5 |
5. Lipitor |
Pfizer |
$310.84 (20mg) |
1.6 |
1.3 |
3.6 |
Generic:
Drug |
Price* |
Satisfaction |
Helpful |
Concern |
1. lovastatin |
$4.69 (20mg) |
2.3 |
2.9 |
3.3 |
2. pravastatin |
$8.34 (40mg) |
2.2 |
3.7 |
4.1 |
3. simvastatin |
$2.81 (20mg) |
1.6 |
1 |
4.1 |
4. atorvastatin |
$8.99 (20mg) |
1.4 |
1.3 |
4 |
* The prices listed refer to a 30-day supply of the most common dosage before any insurance co-pays or drug discounts. The prices listed for prescription medications are provided by OneRx before any insurance co-pays or drug discounts.
** Vytorin is a combo pill of Zetia (ezetimibe) and Zocor (simvastatin)
"By ranking consumers' experiences of their satisfaction with statins, we hope to empower individuals with information based on the experiences of other patients. We want patients to be more confident in their discussions with their doctor when picking a statin to meet their needs," says Ido Hadari, CEO of Treato. "We anticipate that a year from now the rankings of treatments for high cholesterol will look very different with the recent FDA approvals of first-in-class PCSK9 inhibitors Praluent and Repatha, both of which are anticipated to be blockbusters."
Treato's Top List of Statin's was created with data from OneRx, the authority on consumer drug pricing information. OneRx is a free prescription management app that helps insured and uninsured Americans save on medications. Additionally, the OneRx National Drug Index is the only prescription drug price index in the U.S. that measures the average price of prescription drugs, driven by the most commonly prescribed medications. OneRx is part of Truveris, the leading health IT company with a suite of solutions servicing the pharmacy value chain.
Find more information here about Treato's statins drug ratings
Treato's Methodology:
TreatoVoice is a unique data asset that continuously collects and analyzes more than two billion patient and caregiver conversations happening across the Internet to understand what patients are saying about their experiences with their conditions and treatments. Within TreatoVoice, we have the capability to algorithmically identify and rank patients' experiences with medications within their Web posts based on the following methodologies:
- Treato Satisfaction scores are overall drug scores that are calculated based on a ratio of positive to negative reviews about a medication with weight given to the volume and recency of conversations happening online.
- Treato Helpful scores are condition-specific scores that rank the medication among other medications used to treat the same condition. The score is calculated based on the percentage of online conversations in which patients reported the brand being helpful with relation to that condition out of all the online conversations about that brand and that condition.
- Treato Concern scores are calculated based on the percentage of patient online conversations that raise a concern or discuss a side effect in the conversation compared to all of the conversations about the brand happening online.
To find out more about Treato's drug scores please visit: https://treato.com/treato-drug-scores
About Treato:
Treato™, the leading source of real health insights from millions of real health consumers, uses patented analytics and big data technology to turn billions of disparate online conversations into meaningful social intelligence. With more than two billion posts analyzed and continuously expanding, Treato has partnered with 9 out of the world's top 10 pharmaceutical companies as well as numerous other multi-national pharmaceutical companies and healthcare organizations. Treato.com, its consumer website, helps millions of visitors each month.
Treato is privately held with offices in Israel, New York and Princeton, NJ. Investors include Reed Elsevier Ventures, OrbiMed Partners and New Leaf Venture Partners, among others. For more information please visit https://treato.com/
Allyson Noonan
Media Relations Manager
+1(858)245-7256
[email protected]
Photo - http://photos.prnewswire.com/prnh/20160126/326252-INFO
SOURCE Treato
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article